Infertility in the Older Woman

Schmidt-Sarosi, Cecilia

doi:10.1097/00003081-199812000-00020

Cited by 12 publications

(5 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[105][106][107] Eighty percent of women ages 40 to 43 are capable of conception, although their pregnancy rates are lower. [107][108][109] Based on clinical experience, some experts recommend:…”

Section: Women In Perimenopausementioning

confidence: 99%

Disparities in Contraceptive Access and Provision

Casey

Gómez-Lobo

2013

Semin Reprod Med

View full text Add to dashboard Cite

Even though contraceptive coverage expands under the Patient Protection and Affordable Care Act, reducing disparities in contraceptive access and provision requires that all providers assess their patient's reproductive life plans and that health systems work to minimize institutional and socioeconomic barriers. In this article, the challenges of providing equal access to contraceptive care, as well as recommendations for encouraging the use of effective contraception among all reproductive age women are reviewed.

show abstract

Section: Women In Perimenopausementioning

confidence: 99%

Disparities in Contraceptive Access and Provision

Casey

Gómez-Lobo

2013

Semin Reprod Med

View full text Add to dashboard Cite

show abstract

“…Some women erroneously believe that they no longer need contraception, although statistics show that up to 80% of women aged 40 to 44 years can conceive (Schmidt-Sarosi 1998). For these women, hormonal contraception, which offers protection against undesired pregnancy as well as correction of hormonal imbalance, is more suitable than hormone replacement therapy, which offers only the latter (Kaunitz 2001).…”

Section: The Perimenopausementioning

confidence: 99%

Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review

Graziottin¹

2008

PPA

View full text Add to dashboard Cite

The worldwide introduction of the first, unique patch for hormonal contraception (ethinyl estradiol/norelgestromin, EE/NGMN patch) was widely recognized as a significant event in the development of drug delivery systems. This innovation offers a number of advantages over the oral route, and extensive clinical trials have proved its safety, efficacy, effectiveness, and tolerability. The weekly administration and ease of use/simplicity of the EE/NGMN patch contribute to its acceptability, and help to resolve the two main problems of non-adherence, namely early discontinuation and inconsistent use. The patch offers additional benefits to adolescents (improvement of dysmenorrhea and acne), adults (improvement in emotional and physical well-being, premenstrual syndrome, and menstrual irregularities), and perimenopausal women (correction of hormonal imbalance, modulation of premenopausal symptoms), thus providing high satisfaction rates (in nearly 90% of users). Since its introduction, the transdermal contraceptive patch has proved to be a useful choice for women who seek a convenient formulation which is easy to use, with additional, non-contraceptive tailored benefits for all the ages.

show abstract

“…First, a woman who follows the current trend of deferring childbearing until after she has attained tenure (Armenti, 2004) will have reduced fertility when she attempts to conceive. Given that a woman's fertility declines during her 30s, dropping markedly some time in the middle of this decade (e.g., Frank, Bianchi, & Campana, 1994;Schmidt-Sarosi, 1998), even someone who begins her doctoral program immediately after college and gains tenure in her first academic position has diminished reproductive capacity by this point. Postponing childbearing until after tenure is not viable for many (untenured) assistant professors, whose average age is closer to 40 (Jacobs & Winslow, 2004a).…”

Section: Career-family Balancing Challenges Of Faculty Womenmentioning

confidence: 99%